TMates review

TMates keeps the format choice from changing the advertised price

TMates lists semaglutide at $249 monthly and tirzepatide at $297 on its ordinary one-month plans. The company advertises the same price across doses and the same price for oral and injectable forms within each molecule. That makes the format conversation less dependent on an extra oral-product charge. It does not mean the preparations are clinically interchangeable or that choosing a pill is appropriate for everyone. Ask the clinician about the actual formulation, prescribed schedule and reasons for selecting it. The program offers compounded treatment rather than the equivalent menu of FDA-approved branded products.

The monthly prices include medication and ongoing support, with consultation described as part of the program. Before assuming every practical cost is covered, establish the shipping arrangement, supplied quantity and process for dose changes. An unchanged dose price is useful when planning a budget, but it does not explain how a new prescription affects an order already prepared. Public product pages display the commitment ladder, making it possible to compare totals without treating the lowest number as the standard monthly option. The clinician still determines whether a prescription is appropriate after reviewing the health history.

The annual figures require a large payment at enrollment

Semaglutide costs $650 for three months, $1,050 for six and $1,900 for twelve, advertised as approximately $217, $175 and $158 monthly. Tirzepatide is $800 for three months, $1,299 for six and $1,999 for twelve, approximately $267, $217 and $167 monthly. The displayed monthly amounts are rounded equivalents of the larger totals. They are not charges available one month at a time. Compare the total commitment with the period you expect to continue, rather than choosing an annual rate simply because it looks close to another provider's flexible monthly price.

TMates' dose selection spans standard semaglutide and tirzepatide ranges without changing the stated price, and the oral or injection selection does not change the advertised ladder. Even so, verify which product and quantity the final order covers. A longer-term discount does not establish that all medication is dispensed immediately or that unused supply can be refunded later. Ask about shipment timing, preparation deadlines and the terms for a medically necessary pause before committing to six or twelve months. Financing a bundle can spread its payment without making it a cancelable one-month subscription.

Availability and follow-up are the less visible parts

The service does not publish a complete state list. Confirm your location and chosen format before a lengthy intake, and ask whether an upcoming move would affect further prescribing. Also identify the clinical team and dispensing pharmacy for your order, rather than assuming the same organization handles both. Ongoing support is included in the description, but the practical details matter: ask how to reach a clinician, whether a live conversation is available when needed and how refill problems are handled. A clear price ladder is valuable without answering every question about the continuing care relationship.

TMates does not describe a dedicated postpartum, breastfeeding or PCOS service. A mother considering treatment around reproductive plans should make those concerns part of the prescribing discussion before buying a long supply. The program is most relevant to someone who wants to explore both formats at a fixed molecule-specific price and can evaluate the prepaid totals comfortably. Someone who only needs a short commitment should focus on $249 and $297, not the annual equivalents. The best financial choice depends on the actual prescription, state access and cancellation conditions as well as the advertised saving from a longer term.